Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective controlled study of blood lipids in chronic hepatitis B patients treated with nucleos(t)ide analogues
ChiCTR2100048953Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of entecavir, tenofovir disoproxil fumarate and tenofovir alafenamide in Chronic Hepatitis B (CHB) (3 arms), sponsored by Shanghai Public Health Clinical Center. Primary endpoints: total cholesterol, triglyceride and 2 more. Planned start May 2021; status: not yet recruiting.
02
Drugs
entecavirtenofovir disoproxil fumaratetenofovir alafenamide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2100048953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048953.